Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pain block could speed recovery after lung surgery

NCT ID NCT07512635

Recruiting now Symptom relief Sponsor: Sanming First Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a long-acting numbing drug, liposomal bupivacaine, can improve recovery after lung surgery compared to the standard numbing drug. About 96 adults having lung surgery will receive one of the two drugs before surgery. The main goal is to see if the long-acting version leads to better recovery scores 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
liposomal bupivacaine (Exparel)
What this could lead to
If it works, this could provide longer-lasting pain relief after lung surgery, helping patients recover faster and use fewer opioids.
What could go wrong
This is a small, early-phase trial with only 96 participants. The long-acting drug may not significantly improve recovery or could have side effects like any numbing medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPOSOMAL BUPIVACAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIPOSOMAL BUPIVACAINE PULMONARY NODULE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • SanMing First Hospital

    RECRUITING

    Sanming, Fujian, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.